Luciana Kikuchi Selected Research

regorafenib

1/2019

Regorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luciana Kikuchi Research Topics

Disease

5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2014
2	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2016
2	Infections 12/2015 - 01/2010
1	Hypophosphatemia 01/2019
1	HIV Seropositivity 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Fibrosis (Cirrhosis) 03/2017
1	Diarrhea 03/2017
1	Hemorrhage 12/2015
1	Portal Hypertension 12/2015
1	Hepatitis B 12/2015
1	Neoplasms (Cancer) 02/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2010
1	Hepatitis C 01/2010

Drug/Important Bio-Agent (IBA)

1	regorafenibIBA 01/2019
1	Cytidine Triphosphate (CTP)IBA 01/2019
1	Fetal Proteins (Fetoprotein)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 03/2017
1	Interferon LambdaIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	amsonic acid (DAS)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2015

Therapy/Procedure

4	Therapeutics 01/2019 - 01/2010
1	Drug Therapy (Chemotherapy) 01/2019
1	Duration of Therapy 03/2017
1	Splenectomy 12/2015
1	Palliative Care (Palliative Therapy) 12/2015
1	Radiofrequency Ablation 02/2014